Workshop. 3: Antivirals and vaccination for influenza

Improving surveillance of the impact of influenza and its prevention in Canada.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2005

Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.

Vaccine·2003

Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

The Japanese experience with vaccinating schoolchildren against influenza.

The New England journal of medicine·2001

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

PharmacoEconomics·2026

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

PharmacoEconomics·2026

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

PharmacoEconomics·2026

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

PharmacoEconomics·2026

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

PharmacoEconomics·2026

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

PharmacoEconomics·2026

Neoadjuvant therapy combined with immunotherapy for anal sphincter preservation rate, clinical efficacy, and safety in rectal cancer patients: a meta-analysis.

Frontiers in oncology·2026

Structured peptides as vaccine antigens against infections.

Frontiers in immunology·2026

Interferon-Mediated Regulation of Memory B Cell Identity and Function.

Immunological reviews·2026

Pulmonary Cryptococcosis in Apparently Immunocompetent Hosts: Host Susceptibility, Occult Immunodeficiency and Clinical Implications.

Mycoses·2026

Association between helminth infection and impaired SARS-CoV-2 antibody responses following COVID-19 vaccination: a cross-sectional study in Malawi.

Scientific reports·2026

Type 2 immunity in Clostridioides difficile infection.

Anaerobe·2026

Related Experiment Videos

Workshop. 3: Antivirals and vaccination for influenza

Related Concept Videos

Improving surveillance of the impact of influenza and its prevention in Canada.

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.

Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.

Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective.

The Japanese experience with vaccinating schoolchildren against influenza.

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

Neoadjuvant therapy combined with immunotherapy for anal sphincter preservation rate, clinical efficacy, and safety in rectal cancer patients: a meta-analysis.

Structured peptides as vaccine antigens against infections.

Interferon-Mediated Regulation of Memory B Cell Identity and Function.

Pulmonary Cryptococcosis in Apparently Immunocompetent Hosts: Host Susceptibility, Occult Immunodeficiency and Clinical Implications.

Association between helminth infection and impaired SARS-CoV-2 antibody responses following COVID-19 vaccination: a cross-sectional study in Malawi.

Type 2 immunity in Clostridioides difficile infection.

Related Experiment Videos

Workshop. 3: Antivirals and vaccination for influenza

Related Concept Videos

Related Articles